Although currently small and narrowly focussed on a few disease areas and countries, the Biosimilars landscape is set to expand as patents expire on leading biologics, US legislation comes into effect, vision for pharma emerging markets and payers push for their wider adoption to manage burgeoning costs. The signs are visible, but questions remain. How […]
-
Signs That the Future Is a Lot Closer Than You Think Apr 26, 2021
-
5 Benefits of Monoclonal Antibodies Oct 6, 2021
-
How Has Technology Transformed Healthcare? Jun 23, 2021
-
Rethinking Drug Discovery Apr 5, 2023
-
Rethinking Drug Discovery Mar 29, 2023
-
Technology That’s Helping Create Targeted Drugs Sep 12, 2022
-
How To Improve Pharma Care In South-East Asia Mar 22, 2022
-
Is The World Ready For A Mental Health Pandemic? Mar 7, 2022
-
Yaqoob on The Six Great Shifts
Really Informative article from Mr.
-
Yaqoob on The Arab Drug Industry
Arab Drug Industry is dominating but need to concentrate on (...)
-
Yaqoob on Outsourcing preclinical and clinical R&D to China
China is leading the world in R&D as they have low-cost (...)
-
Ameeruddin on Next Generation Pharmacovigilance
I really like the article and the way it was editing... The (...)
-
Ameeruddin on Quality Challenges in Drug Delivery
I really like the article and the way it was edited... The (...)